DarioHealth (DRIO) Scheduled to Post Quarterly Earnings on Thursday

DarioHealth (NASDAQ:DRIOGet Free Report) is scheduled to announce its earnings results before the market opens on Thursday, August 8th. Analysts expect the company to announce earnings of ($0.29) per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

DarioHealth (NASDAQ:DRIOGet Free Report) last posted its earnings results on Wednesday, May 15th. The company reported ($0.20) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.59) by $0.39. DarioHealth had a negative net margin of 282.38% and a negative return on equity of 76.11%. The firm had revenue of $5.76 million during the quarter, compared to analyst estimates of $5.95 million. On average, analysts expect DarioHealth to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

DarioHealth Stock Performance

DRIO stock traded up $0.01 on Tuesday, reaching $0.98. The company’s stock had a trading volume of 40,291 shares, compared to its average volume of 123,297. The firm has a fifty day moving average of $1.24 and a two-hundred day moving average of $1.56. The company has a debt-to-equity ratio of 0.31, a current ratio of 2.95 and a quick ratio of 2.67. The company has a market capitalization of $29.32 million, a P/E ratio of -0.52 and a beta of 1.53. DarioHealth has a 52 week low of $0.68 and a 52 week high of $3.55.

DarioHealth Company Profile

(Get Free Report)

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Featured Articles

Earnings History for DarioHealth (NASDAQ:DRIO)

Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.